Abstract
Gastric cancer is a common malignant tumor of digestive tract tumors. TLR4 is a natural immune cell regulator. In recent years, the molecular mechanism and prevention and treatment of TLR4-related pathways affecting the progression of gastric cancer have become a hot topic. This paper reviews TLR4 and its related signaling pathways, the correlation between TLR4-related pathways and gastric cancer, and the regulation of TLR4-related signaling pathways in the treatment of gastric cancer, in order to provide more evidence for new approaches to treat gastric cancer in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Academic Journal of Medicine & Health Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
